Millipore and CXR Biosciences launch drug screening platform products

Published: 8-Mar-2007
Manufacturing Sustainability Research & Development

US-based Millipore Corporation and CXR Biosciences, of Scotland, have launched their first jointly developed products for the pre-clinical drug development marketplace.

US-based Millipore Corporation and CXR Biosciences, of Scotland, have launched their first jointly developed products for the pre-clinical drug development marketplace.

These products, several of which address unmet market needs, are antibodies that identify key enzymes and transcription factors important in drug metabolism and its regulation. The product portfolio includes:

  • Human Cytochrome P450 CYP2D6
  • Human Cytochrome P450 CYP2A6
  • Human Cytochrome P450 Reductase (POR)
  • Human Pregnane X Receptor (PXR)
  • Human Constitutive Androstane receptor (CAR)
  • Human Farnesoid X Receptor (FXR) (27 to 143)
  • Human Farnesoid X Receptor (FXR) (322 to 472)
Announced as a joint co-development agreement in 2005, the partnership strengthens Millipore's increasing presence in the preclinical drug testing market and launches CXR's entry into the reagent industry. Future co-development efforts will be focused on building predictive toxicity and drug metabolism screens to profile compounds in various cell based and in vitro assays.

See more

You may also like

Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Read more
Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Manufacturing

Limula partners with leading cancer centre to improve blood product processing for stem cell transplantation

The company will collaborate with Institut Paoli-Calmettes to advance haematopoietic stem cell (HSC) processing for transplants
Drug Delivery

Tiziana receives grant for intranasal anti-CD3 monoclonal antibody therapy for spinal cord injury

The US Department of Defense awarded the biotechnology company a research grant to study the use of intranasal anti-CD3 therapy in traumatic spinal cord injury (SCI)
Subscribe now